Symbiox Investment & Trading Co Ltd
BSE:539278
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Symbiox Investment & Trading Co Ltd
BSE:539278
|
IN |
|
4
|
4Sc AG
XETRA:VSC
|
DE |
|
F
|
Fujian Apex Software Co Ltd
SSE:603383
|
CN |
|
N1 Holdings Ltd
ASX:N1H
|
AU |
|
I
|
Inform P Lykos SA
XBER:IPL
|
GR |
|
H
|
Hubei Jianghan New Materials Co Ltd
SSE:603281
|
CN |
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
CN |
Balance Sheet
Balance Sheet Decomposition
Symbiox Investment & Trading Co Ltd
Symbiox Investment & Trading Co Ltd
Balance Sheet
Symbiox Investment & Trading Co Ltd
| Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
0
|
1
|
6
|
5
|
1
|
2
|
2
|
1
|
0
|
1
|
2
|
5
|
3
|
11
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
2
|
5
|
3
|
8
|
|
| Cash Equivalents |
0
|
1
|
6
|
5
|
1
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
|
| Short-Term Investments |
0
|
1
|
307
|
300
|
133
|
146
|
150
|
166
|
169
|
179
|
175
|
127
|
99
|
127
|
|
| Total Receivables |
2
|
0
|
0
|
5
|
176
|
171
|
172
|
13
|
0
|
152
|
141
|
193
|
214
|
166
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
3
|
16
|
13
|
0
|
0
|
9
|
8
|
0
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
176
|
168
|
156
|
0
|
0
|
152
|
132
|
185
|
214
|
165
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
13
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
159
|
150
|
0
|
0
|
0
|
1
|
3
|
|
| Total Current Assets |
2
|
2
|
313
|
309
|
311
|
319
|
325
|
338
|
320
|
332
|
318
|
328
|
318
|
320
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
2
-5%
|
313
+17 300%
|
310
-1%
|
311
+0%
|
319
+3%
|
325
+2%
|
338
+4%
|
320
-5%
|
333
+4%
|
318
-4%
|
328
+3%
|
318
-3%
|
320
+0%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
1
|
7
|
11
|
26
|
7
|
22
|
6
|
13
|
2
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
3
|
3
|
5
|
4
|
1
|
2
|
2
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
|
| Total Current Liabilities |
3
|
3
|
5
|
4
|
2
|
9
|
13
|
27
|
8
|
23
|
6
|
14
|
3
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
3
|
3
|
3
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
3
-6%
|
7
+123%
|
4
-38%
|
5
+5%
|
12
+167%
|
16
+34%
|
29
+82%
|
11
-63%
|
23
+110%
|
6
-72%
|
14
+122%
|
3
-79%
|
2
-21%
|
|
| Equity | |||||||||||||||
| Common Stock |
3
|
3
|
313
|
313
|
313
|
313
|
313
|
313
|
313
|
313
|
313
|
313
|
313
|
313
|
|
| Retained Earnings |
4
|
4
|
7
|
7
|
7
|
6
|
4
|
4
|
4
|
3
|
1
|
0
|
2
|
4
|
|
| Total Equity |
1
N/A
|
1
+7%
|
306
N/A
|
306
0%
|
306
+0%
|
307
+0%
|
308
+0%
|
309
+0%
|
309
+0%
|
310
+0%
|
312
+1%
|
313
+1%
|
315
+1%
|
317
+1%
|
|
| Total Liabilities & Equity |
2
N/A
|
2
-5%
|
313
+17 300%
|
310
-1%
|
311
+0%
|
319
+3%
|
325
+2%
|
338
+4%
|
320
-5%
|
333
+4%
|
318
-4%
|
328
+3%
|
318
-3%
|
320
+0%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
31
|
31
|
31
|
31
|
31
|
31
|
31
|
31
|
31
|
31
|
31
|
31
|
31
|
31
|
|